Jun 2026 (Q2 FY26) — Aug 7, 2026
Concentra Q2 FY26 — Strong Revenue and EBITDA Growth, Accelerated Deleveraging
Read the full callConcentra (CON) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Concentra earnings: last reported Fri, 7 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 606 | +10.0% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 19.0 | +2.7 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 65.3 | +46.5% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Guidance
What management said, and what became of it
11 of 11 judged targets kept · 18 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Net leverage ratio target of approximately 3.0x | approximately 3.0x net leverage within the next 18 to 24 months | Dec 2024 | Our net leverage ratio per our credit agreement at the end of June was just under 3x, down from 3.4x at the end of the first quarter. | Achieved |
| Full-year adjusted EBITDA | $450 million to $470 million | Dec 2025 | resulting in a new adjusted EBITDA range of $485 million to $495 million | Revised Up |
| Full-year capital expenditures | $70 million to $80 million | Dec 2025 | Our target CapEx range of $70 million to $80 million remains unchanged. | On Track |
18 of Concentra Group Holdings Parent, Inc.'s 29 targets are still open. See which are on track and which have gone quiet. The 3 above are the free sample; 26 more targets are in the full ledger.
Claimed
- Total company revenue grew 10% YoY to $606 million, with core revenue up 8% excluding Pivot acquisition.
- Adjusted EBITDA increased 22.5% to $140.9 million, with adjusted EBITDA margin expanding 240 bps to 23.3%.
- Adjusted EPS grew approximately 40% to $0.52, and adjusted net income increased to $66.7 million.
- Net leverage ratio decreased to just under 3x, ahead of schedule, from 3.4x in Q1.
- Free cash flow totaled $121 million, an increase from $63.2 million in the prior year.
Qualified
Price
$38.18 −0.93% · −$0.36
Performance +91.7% 1Y
1Y: $19.92 on 17 Oct 2025 → $38.18. High $39.15 (15 Oct 2026), low $18.71 (6 Nov 2025).
- Previous close
- $38.54
- 52-week range
- $18.71 – $39.15
- One year
- +89.29%
Overview
- Symbol
- CON
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Guidance
What management said, and what became of it
11 of 11 judged targets kept · 18 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Net leverage ratio target of approximately 3.0x | approximately 3.0x net leverage within the next 18 to 24 months | Dec 2024 | Our net leverage ratio per our credit agreement at the end of June was just under 3x, down from 3.4x at the end of the first quarter. | Achieved |
| Full-year adjusted EBITDA | $450 million to $470 million | Dec 2025 | resulting in a new adjusted EBITDA range of $485 million to $495 million | Revised Up |
| Full-year capital expenditures | $70 million to $80 million | Dec 2025 | Our target CapEx range of $70 million to $80 million remains unchanged. | On Track |
Claimed
- Total company revenue grew 10% YoY to $606 million, with core revenue up 8% excluding Pivot acquisition.
- Adjusted EBITDA increased 22.5% to $140.9 million, with adjusted EBITDA margin expanding 240 bps to 23.3%.
- Adjusted EPS grew approximately 40% to $0.52, and adjusted net income increased to $66.7 million.
- Net leverage ratio decreased to just under 3x, ahead of schedule, from 3.4x in Q1.
- Free cash flow totaled $121 million, an increase from $63.2 million in the prior year.
Qualified
The full ledger
Open Concentra Group Holdings Parent, Inc.’s full ledger
A free account opens 5 company ledgers a month. All 29 tracked commitments, with each call’s wording and source.
Call summaries
Mar 2026 (Q1 FY26) — May 8, 2026
Concentra Q1 FY26 — Strong Start Driven by Workers' Comp and Onsite Health Growth
Read the full callDec 2025 (Q4 FY25) — Feb 27, 2026
Concentra Q4 FY25 — Strong Finish to Solid Year, Exceeding Guidance
Read the full callEvery analysed call
Concentra earnings calls (CON)
Financials
What the filings say
Net profit, year on year: +47% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 490 | 465 | 501 | 551 | 573 | 539 | 570 | 606 |
| Expenses | 403 | 406 | 420 | 461 | 478 | 469 | 474 | 491 |
| Operating profit | 86 | 59 | 80 | 90 | 94 | 70 | 96 | 115 |
| Operating margin | 17.6% | 12.7% | 16.0% | 16.3% | 16.5% | 12.9% | 16.8% | 19.0% |
| Interest | — | — | 26 | — | — | — | 26 | — |
| Profit before tax | 62 | 33 | 54 | 61 | 66 | 43 | 70 | 89 |
| Tax rate | 26.4% | 30.2% | 24.6% | 24.7% | 24.3% | 15.4% | 24.9% | 24.7% |
| Net profit | 44 | 22 | 39 | 45 | 48 | 35 | 50 | 65 |
| EPS ($ per share) | 0.37 | — | 0.30 | 0.35 | 0.38 | — | 0.39 | 0.51 |
| Line item | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Equity capital | — | 0 | 1 | 1 |
| Reserves | — | 685 | 14 | 146 |
| Total liabilities | 1,318 | 1,156 | 2,222 | 2,438 |
| Fixed assets | — | 178 | 198 | 225 |
| Total assets | 2,297 | 2,334 | 2,521 | 2,858 |
| Line item | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Cash from operations | 274 | 234 | 275 | 279 |
| Cash from investing | -58 | -75 | -71 | -415 |
| Cash from financing | -210 | -165 | -52 | 32 |
| Net cash flow | 7 | -6 | 152 | -103 |
| Capital expenditure | -46 | -65 | -64 | -82 |
| Free cash flow | 228 | 169 | 210 | 197 |
CON revenue by segment
Occupational Health Center shrank from 94% to 91% of revenue over the last two years.
| Segment | Q2 FY2024 | Q3 FY2024 | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | YoY growth latest quarter |
|---|---|---|---|---|---|---|---|---|---|
| Occupational Health Center | 94% | 95% | 94% | 94% | 92% | 91% | 91% | 91% | +7.2% |
| Onsite Health Clinics | — | 3% | 3% | 4% | 6% | 7% | 7% | 6% | +72.1% |
| Other Businesses | 2% | 2% | 2% | 2% | 2% | 2% | 2% | 2% | +13.3% |
Share of consolidated revenue by quarter. Q4 is the fiscal year less its first three quarters.
See how segments are shifting across companies → Segment Shift
Insider filings
47 filings between Nov 4, 2025 and Aug 21, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$14.60M
4 sales by 1 insider
100% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 22
- Award — granted as compensation
- 13
- Tax withheld — shares kept back by the company to cover tax
Also filed: 5 dispositions to the issuer, 3 gifts.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| ORTENZIO ROBERT A | — | $14.60M | Aug 3, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Aug 21, 2026 | ORTENZIO ROBERT A Director | Disposition to issuer | 30,000 | $1.04M |
| Aug 21, 2026 | ORTENZIO ROBERT A Director | Disposition to issuer | 770,000 | $26.68M |
| Aug 21, 2026 | ORTENZIO ROBERT A Director | Disposition to issuer | 150,000 | $5.20M |
| Aug 21, 2026 | ORTENZIO ROBERT A Director | Disposition to issuer | 30,000 | $1.04M |
| Aug 21, 2026 | ORTENZIO ROBERT A Director | Disposition to issuer | 20,000 | $693.0K |
| Aug 3, 2026 | ORTENZIO ROBERT A Director | Sale 10b5-1 plan | 130,000 | $4.14M |
| Jul 1, 2026 | ORTENZIO ROBERT A Director | Sale 10b5-1 plan | 130,000 | $3.96M |
| Jun 1, 2026 | ORTENZIO ROBERT A Director | Sale 10b5-1 plan | 130,000 | $3.25M |
| May 8, 2026 | ORTENZIO ROBERT A Director | Sale 10b5-1 plan | 130,000 | $3.25M |
| Dec 17, 2025 | Newton William Keith Chief Executive Officer | Gift | 89,081 | $0 |
| Dec 17, 2025 | Newton William Keith Chief Executive Officer | Gift | 89,081 | $0 |
| Nov 26, 2025 | Kosuth Michael A. See Remarks | Tax withheld | 6,449 | $135.7K |
| Nov 26, 2025 | Ryan Timothy F. See Remarks | Tax withheld | 5,903 | $124.2K |
| Nov 26, 2025 | Anderson John Robert Jr. See Remarks | Tax withheld | 6,540 | $137.6K |
| Nov 26, 2025 | Gallara Giovanni See Remarks | Tax withheld | 6,563 | $138.1K |
| Nov 26, 2025 | Conser Jonathan P. See Remarks | Tax withheld | 5,903 | $124.2K |
| Nov 26, 2025 | DiCanio Matthew T. See Remarks | Tax withheld | 17,708 | $372.6K |
| Nov 26, 2025 | Kendall Danielle See Remarks | Tax withheld | 3,935 | $82.8K |
| Nov 26, 2025 | Rhine Michael D. See Remarks | Tax withheld | 3,935 | $82.8K |
| Nov 26, 2025 | Gilbert Greg M. See Remarks | Tax withheld | 5,903 | $124.2K |
| Nov 26, 2025 | Devasia Thomas A. See Remarks | Tax withheld | 5,903 | $124.2K |
| Nov 26, 2025 | Nelson Su Zan See Remarks | Tax withheld | 5,903 | $124.2K |
| Nov 26, 2025 | McAndrew Douglas R. See Remarks | Tax withheld | 5,903 | $124.2K |
| Nov 26, 2025 | deLorimier John A. See Remarks | Tax withheld | 6,428 | $135.2K |
| Nov 25, 2025 | ORTENZIO ROBERT A Director | Gift | 100,000 | $0 |
| Nov 4, 2025 | Devasia Thomas A. See Remarks | Award | 60,000 | $0 |
| Nov 4, 2025 | Bonner Brigid A. Director | Award | 7,748 | $0 |
| Nov 4, 2025 | Bonner Brigid A. Director | Award | 7,748 | $0 |
| Nov 4, 2025 | Watkins Marc R. Director | Award | 7,748 | $0 |
| Nov 4, 2025 | Gilbert Greg M. See Remarks | Award | 60,000 | $0 |
| Nov 4, 2025 | deLorimier John A. See Remarks | Award | 60,000 | $0 |
| Nov 4, 2025 | Pegus Cheryl Director | Award | 7,748 | $0 |
| Nov 4, 2025 | Conser Jonathan P. See Remarks | Award | 60,000 | $0 |
| Nov 4, 2025 | Anderson John Robert Jr. See Remarks | Award | 60,000 | $0 |
| Nov 4, 2025 | Nelson Su Zan See Remarks | Award | 60,000 | $0 |
| Nov 4, 2025 | Kendall Danielle See Remarks | Award | 40,000 | $0 |
| Nov 4, 2025 | ORTENZIO ROBERT A Director | Award | 7,748 | $0 |
| Nov 4, 2025 | McAndrew Douglas R. See Remarks | Award | 60,000 | $0 |
| Nov 4, 2025 | Gopal Vipin Director | Award | 7,748 | $0 |
| Nov 4, 2025 | Gopal Vipin Director | Award | 7,748 | $0 |
| Nov 4, 2025 | Ryan Timothy F. See Remarks | Award | 60,000 | $0 |
| Nov 4, 2025 | Newton William Keith Chief Executive Officer | Award | 225,000 | $0 |
| Nov 4, 2025 | Thomas Daniel Director | Award | 7,748 | $0 |
| Nov 4, 2025 | Gallara Giovanni See Remarks | Award | 60,000 | $0 |
| Nov 4, 2025 | DiCanio Matthew T. See Remarks | Award | 180,000 | $0 |
| Nov 4, 2025 | Kosuth Michael A. See Remarks | Award | 60,000 | $0 |
| Nov 4, 2025 | Rhine Michael D. See Remarks | Award | 40,000 | $0 |
| Mar 3, 2025 | ORTENZIO ROBERT A Director | Other | 3,070,367 | $0 |
| Mar 3, 2025 | ORTENZIO ROBERT A Director | Other | 1,023,455 | $0 |
| Nov 26, 2024 | Anderson John Robert Jr. See Remarks | Award | 60,000 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Concentra Group Holdings Parent, Inc.
Free account. Everything above stays public.
Write why you follow Concentra Group Holdings Parent, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading